Edgewise Therapeutics Inc... (EWTX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
28.63
1.11 (4.03%)
At close: Jan 15, 2025, 11:47 AM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
PE Ratio | -6.96 | -31.12 | -17.95 | -86.58 | -155.65 |
PS Ratio | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 2.19 | 1.38 | 2.76 | -44.18 | -87.61 |
P/FCF Ratio | -7.14 | -8.24 | -22.13 | -99.52 | -157.9 |
P/OCF Ratio | -7.58 | -9.1 | -22.57 | -100.9 | -161 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.02 | 0.01 | n/a | -4.79 | -2.39 |
Quick Ratio | 19.50 | 21.22 | 26.69 | 29.86 | 21.24 |
Current Ratio | 19.50 | 21.22 | 26.69 | 29.86 | 21.24 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | -5.5 | n/a | n/a | n/a |
Return on Equity (ROE) | -0.31 | -0.04 | -0.15 | 0.51 | 0.56 |
Return on Assets (ROA) | -0.29 | -0.04 | -0.15 | -0.13 | -0.39 |
Return on Capital (ROIC) | -0.35 | -0.06 | -0.16 | -0.14 | -0.42 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a |